aminoglutethimide has been researched along with prednisolone in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Hamilton, W | 1 |
| Gower, DB; Lessof, MH; Lyne, C | 1 |
| Hamilton, W; Moodie, T | 1 |
| Bühler, H; Hundertmark, S; Ragosch, V; Rudolf, M; Weitzel, HK | 1 |
7 other study(ies) available for aminoglutethimide and prednisolone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Long-term effects of aminoglutethimide on steroid metabolism in congenital adrenal hyperplasia.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Hyperplasia, Congenital; Adrenocortical Hyperfunction; Aminoglutethimide; Child; Child, Preschool; Cholesterol; Chromatography, Gas; Chromatography, Thin Layer; Female; Humans; Prednisolone; Pregnadienetriols; Steroid Hydroxylases; Time Factors | 1976 |
The effects of aminoglutethimide and prednisolone on steroid excretion in cases of carcinoma of the breast.
Topics: Aminoglutethimide; Aniline Compounds; Anticonvulsants; Breast Neoplasms; Estrogens; Female; Glucocorticoids; Humans; Prednisolone; Pyridones; Steroids | 1971 |
The treatment of congenital adrenal hyperplasia with aminoglutethimide.
Topics: Adrenal Cortex Hormones; Adrenal Gland Diseases; Aminoglutethimide; Aniline Compounds; Anticonvulsants; Chemical Phenomena; Chemistry; Child, Preschool; Female; Growth; Humans; Hyperplasia; Infant; Infant, Newborn; Male; Prednisolone; Pyridones | 1970 |
Inhibition of 11 beta-hydroxysteroid dehydrogenase activity enhances the antiproliferative effect of glucocorticosteroids on MCF-7 and ZR-75-1 breast cancer cells.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Administration, Topical; Aminoglutethimide; Analysis of Variance; Anti-Inflammatory Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cell Division; Cells, Cultured; Dexamethasone; Female; Glucocorticoids; Glycyrrhetinic Acid; Humans; Hydroxysteroid Dehydrogenases; Prednisolone; Tamoxifen; Tumor Cells, Cultured | 1997 |